Various studies show the inhibition of the proliferation and metastasis properties of cancer cells when treated with sinulariolide through downregulation of PI3K/mTOR and p38MAPK pathways in bladder and hepatic cancer [112,113]. The gene discussed is MTOR; the disease is cancer.